| 2024年年报 | 2023年年报 | |
|---|---|---|
| 营业收入(元) | ||
| CDMO(元) | 121,707,818.30 | 200,518,499.42 |
| 贸易类(元) | 48,358,520.42 | 40,184,207.92 |
| 原料药及中间体(元) | 792,657,971.97 | 747,070,235.29 |
| 制剂类(元) | 405,469,948.85 | 220,934,775.24 |
| 营业成本(元) | ||
| CDMO(元) | 82,945,888.84 | 147,661,400.27 |
| 贸易类(元) | 38,611,847.90 | 34,934,570.16 |
| 原料药及中间体(元) | 532,739,317.37 | 525,300,176.87 |
| 制剂类(元) | 267,032,952.68 | 125,942,709.84 |
| 毛利(元) | ||
| CDMO(元) | 38,761,929.46 | 52,857,099.15 |
| 贸易类(元) | 9,746,672.52 | 5,249,637.76 |
| 原料药及中间体(元) | 259,918,654.60 | 221,770,058.42 |
| 制剂类(元) | 138,436,996.17 | 94,992,065.40 |
| 毛利率(%) | ||
| CDMO(%) | 31.85 | 26.36 |
| 贸易类(%) | 20.16 | 13.06 |
| 原料药及中间体(%) | 32.79 | 29.69 |
| 制剂类(%) | 34.14 | 43.00 |
| 收入构成(%) | ||
| CDMO(%) | 8.90 | 16.59 |
| 贸易类(%) | 3.53 | 3.32 |
| 原料药及中间体(%) | 57.93 | 61.81 |
| 制剂类(%) | 29.64 | 18.28 |
| 毛利构成(%) | ||
| CDMO(%) | 8.67 | 14.10 |
| 贸易类(%) | 2.18 | 1.40 |
| 原料药及中间体(%) | 58.17 | 59.16 |
| 制剂类(%) | 30.98 | 25.34 |